Literature DB >> 1721449

FK 506: a new therapeutic agent for severe recalcitrant psoriasis.

K Abu-Elmagd1, D Van Thiel, B V Jegasothy, C D Ackerman, S Todo, J J Fung, A W Thomson, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721449

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  FK 506 and autoimmune disease: perspective and prospects.

Authors:  A W Thomson; T E Starzl
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

Review 2.  [Calcineurin inhibitors for topical therapy in psoriasis].

Authors:  J Wohlrab
Journal:  Hautarzt       Date:  2006-08       Impact factor: 0.751

3.  Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by h.p.l.c.-MS and microparticle enzyme immunoassay (MEIA).

Authors:  A K Gonschior; U Christians; F Braun; M Winkler; A Linck; J Baumann; K F Sewing
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

4.  Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.

Authors:  B Lemster; L L Huang; W Irish; J Woo; P B Carroll; K Abu-Elmagd; H R Rilo; N Johnson; R Russell-Hall; J J Fung
Journal:  Autoimmunity       Date:  1994       Impact factor: 2.815

5.  Topical FK506: suppression of allergic and irritant contact dermatitis in the guinea pig.

Authors:  A I Lauerma; B D Stein; B Homey; C H Lee; E Bloom; H I Maibach
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

6.  Sirolimus treatment for cirrhosis or hepatocellular carcinoma patients accompanied by psoriasis after liver transplantation: A single center experience.

Authors:  Lin Zhou; Guo-Sheng Du; Li-Chao Pan; Yong-Gen Zheng; Zhi-Jia Liu; Hai-Da Shi; Shao-Zhen Yang; Xian-Jie Shi; Meng Xuan; Li-Kui Feng; Zhi-Dong Zhu
Journal:  Oncol Lett       Date:  2017-10-18       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.